Matthew E. Korenberg - Dec 28, 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon, Attorney-in-Fact for Matthew E. Korenberg
Stock symbol
LGND
Transactions as of
Dec 28, 2022
Transactions value $
-$255,813
Form type
4
Date filed
12/30/2022, 04:00 PM
Previous filing
Dec 27, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$256K -3.86K -4% $66.29 92.6K Dec 28, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.